Sarfraz A. Tunio

Sarfraz A. Tunio

Auto-generated profile, based on publicly available information

Sarfraz A. Tunio

Molecular Bacteriology and Immunology Group, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, NG7 2RD, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2010 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
STSarfraz A. Tunio
Sarfraz A. Tunio
NONeil Oldfield
Neil Oldfield
ABAlan Berry
Alan Berry
DADlawer A. A. Ala'ALdeen
Dlawer A. A. Ala'ALdeen
KWKarl G. Wooldridge
Karl G. Wooldridge
DTDavid P. J. Turner
David P. J. Turner

9 November 2010 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
STSarfraz A Tunio
Sarfraz A Tunio
NONeil Oldfield
Neil Oldfield
DADlawer Aa Ala'Aldeen
Dlawer Aa Ala'Aldeen
KWKarl G Wooldridge
Karl G Wooldridge
DTDavid Pj Turner
David Pj Turner
Background: Glyceraldehyde 3-phosphate dehydrogenases (GAPDHs) are cytoplasmic glycolytic enzymes, which although lacking identifiable secretion signals, have also been found localized to the surface of several bacteria (and some eukaryotic organisms); where in some cases they have been shown to contribute to the colonization and invasion of host tissues. Neisseria meningitidis is an obligate human nasopharyngeal commensal which can cause life-threatening infections including septicaemia and meningitis. N. meningitidis has two genes, gapA-1 and gapA-2, encoding GAPDH enzymes. GapA-1 has previously been shown to be up-regulated on bacterial contact with host epithelial cells and is accessible to antibodies on the surface of capsule-permeabilized meningococcal cells. The aims of this study were: 1) to determine whether GapA-1 was expressed across different strains of N. meningitidis; 2) to determine whether GapA-1 surface accessibility to antibodies was dependant on the presence of capsule; 3) to determine whether GapA-1 can influence the interaction of meningococci and host cells, particularly in the key stages of adhesion and invasion. Results: In this study, expression of GapA-1 was shown to be well conserved across diverse isolates of Neisseria species. Flow cytometry confirmed that GapA-1 could be detected on the cell surface, but only in a siaD-knockout (capsule-deficient) background, suggesting that GapA-1 is inaccessible to antibody in in vitro-grown encapsulated meningococci. The role of GapA-1 in meningococcal pathogenesis was addressed by mutational analysis and functional complementation. Loss of GapA-1 did not affect the growth of the bacterium in vitro. However, a GapA-1 deficient mutant showed a significant reduction in adhesion to human epithelial and endothelial cells compared to the wild-type and complemented mutant. A similar reduction in adhesion levels was also apparent between a siaD-deficient meningococcal strain and an isogenic siaD gapA-1 double mutant. Conclusions: Our data demonstrates that meningococcal GapA-1 is a constitutively-expressed, highly-conserved surface-exposed protein which is antibody-accessible only in the absence of capsule. Mutation of GapA-1 does not affect the in vitro growth rate of N. meningitidis, but significantly affects the ability of the organism to adhere to human epithelial and endothelial cells in a capsule-independent process suggesting a role in the pathogenesis of meningococcal infection.

24 July 2012 in AFRICAN JOURNAL OF BIOTECHNOLOGY
Verified
Journal Article
Open access
STSarfraz A. Tunio
Sarfraz A. Tunio